Past, present and future of nutrigenomics and its influence on drug development

Current Drug Discovery Technologies

Volumn 10, Issue 1, 2013, Pages 35-46

  Lundstrom, Kenneth ^a  

^a Centre of Kenneth Lundstrcm   (Switzerland)

Author keywords

Dietary intervention; Dietary therapy; Epigenetics; Gene silencing; Micro RNA; Nutrigenomics; Personalized medicine; Prevention

Indexed keywords

HISTONE;

ARTICLE; DIET THERAPY; DNA METHYLATION; DRUG DEVELOPMENT; EPIGENETICS; FAT MASS; GENE EXPRESSION; GENOME; HEALTH CARE COST; HUMAN; MALE; NUTRIGENOMICS; NUTRITION; NUTRITIONAL REQUIREMENT; OBESITY; PRIORITY JOURNAL;

EID: 84875448810     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/1570163811310010006     Document Type: Article

References (132)

1. Brillat-Savarin A. In Physiologie du Gout, ou Meditations de Gastronomie Transcendante 1826.
2. Feuerbach LA. Concerning Spiritualism and Materialism 1864.
3. www.nestleinstitutehealthsciences.com
4. Pareek CS, Smoczynski R, Tretyn A. Sequencing technologies and genome sequencing. J Appl Genet 2011; 52: 413-35.
5. Lundstrom K. Genomics and drug discovery. Future Med Chem 2011; 3: 1855-8.
6. Fernald GH, Capriotti E, Daneshjou R, Karczewski KJ, Altman RB. Bioinformatics challenges for personalized medicine. Bioinformatics 2011; 27: 1741-8.
7. Ferguson LR. Nutrigenomics approaches to functional foods. J Am Diet Assoc 2009; 109: 452-8.
8. Fenech M, El-Sohemy A, Cahill L, et al. Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. J Nutrigenet Nutrigenomics 2011; 4: 69-89.
9. Van Ommen B, Bouwman J, Dragsted L, et al. Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes Nutr 2010; 5: 189-203.
10. Zeisel SH. Nutrigenomics and metabolomics will change clinical nutrition and public health practice: insights from studies on dietary requirements for choline. Am J Clin Nutr 2007; 86: 542-8.
11. Yang JY, Karr JR, Watrous JD, et al. Integrating '-omics' and natural product discovery platforms to investigate metabolic exchange in microbiomes. Curr Opin Chem Biol 2011; 15: 79-87.
12. Su LJ, Mahabir S, Ellison GL, McGuinn LA, Reid BC. Epigenetic contributions to the relationship between cancer and dietary intake of nutrients, bioactive food components and environmental toxicants. Front Genetics 2012; 2: 1-11.
13. Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J Nutr 2007; 137: 223S-228S.
14. Boehm TL, Drahovsky D. Alteration of enzymatic methylation of DNA cytosines by chemical carcinogens; a mechanism involved in the initiation of carcinogenesis. J Natl Cancer Inst 1983; 71: 429-33.
15. Costello JF, Plass C. Methylation matters. J Med Genet 2001; 38: 285-303.
16. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.
17. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009; 21: 243-51.
18. Bollati V, Baccarelli A. Environmental epigenetics. Heredity 2010; 105: 105-12.
19. Lundstrom K. MicroRNA in disease and gene therapy. Curr Drug Discov Technol 2011; 8: 76-86.
20. Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 2010; 71: 3-39.
21. Barros SP, Offenbacher S. Epigenetics: connecting environment and genotype to phenotype and disease. J Dent Res 2009; 88: 400-8.
22. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
23. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998; 12: 949-57.
24. Duhl DM, Vrieling H, Miller K, Wolff GL, Barsh GS. Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994; 8: 59-65.
25. Waterland R, Jirtle R. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293-300.
26. Dobosy JR, Fu VX, Desotelle J, et al. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate. Prostate 2008; 68: 1187-95.
27. Brons C, Jacobsen S, Nilsson E, et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab 2010; 95: 3048-56.
28. Suter M, Bocock P, Showalter L, et al. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J 2011; 25: 714-26.
29. Bull C, Fenech M. Genome-health nutrigenomics and nutrigenetics: nutritional requirements or "nutriomes" for chromosomal stability and telomere maintenance at the individual level. Proc Nutr Soc 2008; 67: 146-56.
30. Wicker T, Sabot F, Hua-Van A, et al. A unified classification system for eukaryotic transposable elements. Nat Rev Genet 2007; 8: 973-82.
31. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science 2004; 303: 1626-32.
32. Bernal AJ, Jirtle RL. Epigenomic disruption: the effects of early developmental exposures. Birth Defect Res Clin Mol Teratol 2010; 88: 938-44.
33. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. Bioessays 2003; 25: 577-88.
34. www.choosemyplate.gov/weight-management-calories.html
35. McGough N, Cummings JH. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc Nutr Soc 2005; 64: 434-50.
36. Romanos J, van Diemen CC, Nolte IM, Trynka G. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009; 137: 834-40.
37. Arkadianos I, Valdes AM, Marinos E, Florou A. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J 2007; 6: 29-35.
38. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-94.
39. Andreasen CH, Stender-Petersen KL, Morgensen MS, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2007; 57: 95-101.
40. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007; 39: 724-6.
41. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 2008; 359: 2558-66.
42. Rampersaud E, Mitchell BD, Pollin TI, et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med 2008; 168: 1791-7.
43. Vimaleswaran KS, Li S, Zhao JH, et al. Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene. Am J Clin Nutr 2009; 90: 425-8.
44. Abbasi F, Brown BW Jr., Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002; 40: 937-43.
45. Tai ES, Ordovas JM. The role of perilipin in human obesity and insulin resistance. Curr Opin Lipidol 2007; 29: 1313-9.
46. Yngve A. A historical perspective of the understanding of the link between diet and coronary heart disease. Am J Lifestyle Med 2009; 3: 35S-38S.
47. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Boston, Harvard University Press, 1980.
48. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction : final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85.
49. Ornisch D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33.
50. Corella D, Ordovas JM. Nutrigenomics in Cardiovascular Medicine. Circ Cardiovasc Genet 2009; 2: 637-51.
51. Low Yl, Tai ES. Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease. Mutat Res 2007; 622: 138-43.
52. Fumeron F, Betouelle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-71.
53. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 1997; 28: 1739-43.
54. Hines LM, Stampher MJ, Ma J, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001; 344: 549-55.
55. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006; 295: 1135-41.
56. Ruis-Narvaez EA, Kraft P, Campos H. Ala12 variant of the peroxisome proliferator-activated receptor gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction. Am J Clin Nutr 2007; 86: 1238-42.
57. Yang Y, Ruis-Narvaez EA, Kraft P, Campos H. Effect of apolipoprotein E genotype and saturated fat intake on plasma lipids and myocardial infarction in the Central Valley of Costa Rica. Hum Biol 2007; 79: 637-47.
58. Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell Biochem 2008; 49: 241-68.
59. Puglielli L. Ageing of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit? Neurobiol Aging 2008; 29: 795-811.
60. Coutts RT, Urichuk LJ. Polymorphic cytochromes P450 and drugs used in psychiatry. Cell Mol Neurobiol 1999; 19: 325-54.
61. Wu X, Tang KF, Li Y, et al. Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: A meta-analysis. Parkinsonism Relat Disord 2012; 18: 722-30.
62. Oster T, Pillot T. Docosahexaenoic acid and synaptic protection in Alzheimer's disease in mice. Biochim Biophys Acta 2010; 1801: 791-8.
63. Chen CM, Yin MC, Hsu CC, Liu TC. Antioxidative and antiinflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice. Nutrition 2007; 23: 589-97.
64. Pocernich CB, Lange ML, Sultana R, Butterfield DA. Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr Alzheimer Res 2011; 8: 452-69.
65. Gu Y, Scarmeas N. Dietary patterns in Alzheimer's disease and cognitive aging. Curr Alzheimer Res 2011; 8: 510-9.
66. Murakami K, Miyake Y, Sasaki S, et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case-control study inJapan. Br J Nutr 2010; 104: 757-64.
67. Miyake Y, Fukushima W, Tanaka K, et al. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur J Neurol 2011; 18: 106-13.
68. Lewis MD, Bailes J. Neuroprotection for the warrior: dietary supplementation withomega-3 fatty acids. Mil Med 2011; 176: 1120-7.
69. Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011; 44: 192-201.
70. Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: anarrative review. Complement Ther Med 2011; 19: 228-37.
71. Genton L, Viatte V, Janssens JP, Héritier AC, Pichard C. Nutritional state, energy intakesand energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr 2011; 30: 553-9.
72. Watts MK. Nutritional therapy in practice for learning, behavioral and mood disorders. Nutr Health 2011; 20: 239-54.
73. Galasko DR, Peskind E, Clark CM, et al. Antioxidants for AlzheimerDisease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures.Arch Neurol 2012; Mar 19. [Epub ahead of print]
74. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-308.
75. World Cancer Research Fund, American Institute of Cancer Research, Diet, Nutritionand Prevention of Human Cancer: A Global Perspective, World Cancer Research Fund, Washington, American Institute of Cancer Research 2007.
76. Lampe JW. Interindividual differences in response to plant-based diets: implications for cancer risk. Am J Clin Nutr 2009; 89: 1553S-1557S.
77. Milner JA. Nutrition and cancer: essential elements for a roadmap. Cancer Lett 2008;269: 189-98.
78. Jeurnink S, Büchner F, Bueno-de-Mesquita H, et al. Variety in vegetableand fruit consumption and the risk of gastric and esophageal cancer in the EuropeanProspective investigation into cancer and nutrition (EPIC). Int J Cancer 2012; Mar 6. doi: 10.1002/ijc.27517. [Epub ahead of print]
79. Cooper R. Green tea and theanine: health benefits. Int J Food Sci Nutr 2012; 63: 90-7.
80. Ong TP, Moreno FS, Ross SA. Targeting the epigenome with bioactive food components for cancer prevention. J Nutrigenet Nutrigenomics 2011; 4: 275-92.
81. Ross SA, Davis CD. MicroRNA, Nutrition, and Cancer Prevention. Adv Nutr 2011; 2: 472-85.
82. Casas F, Leon C, Jovell E, et al. Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status. Clin Transl Oncol 2012; 14: 66-72.
83. Ornish D, Magbanua MJM, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 2008; 105: 8369-74.
84. Kussmann M, Van Bladeren PJ. The extended nutrigenomics - understanding the interplay between the genomes of food, gut microbes, and human host. Front Genet 2011; 2: 1-13.
85. Casado B, Affolter M, Kussmann M. OMICS-rooted studies of milk proteins,oligosaccharides, and lipids. J Proteomics 2009; 73: 196-208.
86. Fong BY, Norris CS, Palmano KP. Fractionation of bovine whey proteins and characterization by proteomic techniques. Int Dairy J 2008; 18: 23-46.
87. Sakata K, Ohyanagi H, Nobori H, Nakamura T, et al. Soybean proteome database: a data resource for plant differential omics. J Proteome Res 2009; 8: 3539-48.
88. Grigorov MG, Van Bladeren PJ. Functional peptides by genome reverse engineering.Curr Opin Drug Discov Devel 2007; 10: 341-6.
89. Severin S, Xia W. Milk biologically active components as nutraceuticals: review. Crit Rev Food Sci Nutr 2005; 45: 645-56.
90. Lampreave E, Pineiro A, Brock JH, Castillo H, Sánchez L, Calvo M. Interaction of bovine lactoferrin with other proteins in milk whey. Int J Biol Macromol 1990; 12: 2-5.
91. Levy J. Immunonutrition: the pediatric experience. Nutrition 1998; 14: 641-7.
92. Erdmann K, Cheung BW, Schroder H. The possible roles of foodderived bioactivepeptides in reducing the risk of cardiovascular disease. J Nutr Biochem 2008; 19: 643-54.
93. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aortaafter oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126: 3063-68.
94. Erickson BE. Proteomics data backup soy health claims. J Proteome Res 2005; 4: 219.
95. Fang N, Yu S, Badger TM. Comprehensive phytochemical profile of soy protein isolate. J Agric Food Chem 2004; 52: 4012-20.
96. de Lumen BO. Lunasin: a cancer-preventive soy peptide. Nutr Rev 2005; 63: 16-21.
97. Grigorov MG, van Bladeren PJ. Functional peptides by genome reverse engineering. Curr Opin Drug Discov Devel 2007; 10: 341-6.
98. Jiang M, Sang X, Hong Z. Beyond nutrients: food-derived miRNA s provide cross kingdom regulation. Bioessays 2012; 34: 280-4.
99. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora arepartners for the protection of the host: report on the Danone symposium "the intelligent intestine", held in Paris, June 14, 2002. Am J Clin Nutr 2003; 78: 675-83.
100. Rabot S, Membrez M, Bruneau A, et al. Gem-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistanceand have altered cholesterol metabolism. FASEB J 2010; 24: 4948-59.
101. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444(7122): 1022-3.
102. Bry I, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996; 273: 1380-3.
103. Biagi E, Candela M, Fairweather-Tait S, Franceschi C, Brigidi P. Ageing of the human metaorganism: the microbial counterpart. Age (Dordr) 2011; 34: 247-67.
104. Ng SC, Benjamin JL, McCarthy NE, et al. Relationship between human intestine dendritic cells, gut microbiota, and disease activity in Chrohn's disease. Inflamm Bowel Dis 2010; 17: 2027-37.
105. Pruteanu M, Hyland NP, Clarke DJ, Kiely B, Shanahan F. Degradation of the extracellular matrix components by bacterial-derived metalloproteases: implications for imflammatory bowel diseases. Imflamm Bowel Dis 2011; 17: 1189-1200.
106. Bourne HR. How receptors talk to trimeric G proteins. Curr Opin Cell Biol 1997; 9: 134-42.
107. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56: 17-28.
108. Hauner H, Meier M, Jockel KH, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy thorugh genotyping of the G protein beta3 subunit (GNB3) C825T polymorphism. Pharmacogenetics 2003; 13: 453-9.
109. Frey UH, Hauner H, Jockel KH, Manthey I, Brockmeyer N, Siffert W. A novel promote polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation. Pharmacogenet Genomics 2008; 18: 141-51.
110. Nurnberger J, Dammer S, Mitchell A, et al. Effect of the C825T polymorphism of the G protein beta 3 subunit on the systemic blood pressure-lowering effect of clonidine in young, healthy male subjects. Clin Pharmacol Ther 2003; 74: 53-60.
111. Bailey LB, Gregory JF III. Polymorphism of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks, and impact on folate requirement. J Nutr 1999; 129: 919-22.
112. Cohen AL, Soldi R, Zhang H, et al. A pharmaco genomic method for individualized prediction of drug sensitivity. Mol Syst Biol 2011; 7: 513-25.
113. García Díaz E, Martín Folgueras T. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents. Nutr Hosp 2011; 26: 451-7.
114. Hsiao TJ, Wu LS, Huang SY, Lin E. A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity Clin Pharmacol 2010; 2: 105-10.
115. Kaput J, Evelo CT, Perozzi G, van Ommen B, Cotton R. Connecting the Human Variome Project to nutrigenomics. Genes Nutr 2010; 5: 275-83.
116. www.humanvariomeproject.org
117. Hyson DA. A comprehensive review of apples and apple components and their relationship to human health. Adv Nutr 2011; 2: 408-20.
118. Dong JY, He K, Wang P, Qin LK. Dietary fiber intake and risk of breast cancer: ameta-analysis of prospective cohort studies. Am J Clin Nutr 2011; 94: 900-5.
119. Dong JY, Zhang L, He K, Qin LQ. Dairy consumption and risk of breast cancer: ameta-analysis of prospective cohort studies. Breast Cancer Res Treat 2011; 127: 23-31.
120. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011; 125: 315-23.
121. Buckland G, Travier N, Agudo A, et al. Olive oil intake and breast cancer risk in the Mediterranean countries of the European prospective investigation into cancer and nutrition (EPIC) study. Int J Cancer 2012; 131(10): 2465-9.
122. Tan EC, Li H. Characterization of frequencies and distribution of single nucleotide insertions/deletions in the human genome. Gene 2006; 376: 268-80.
123. Wicker T, Sabot F, Hua-Van A, et al. A unified classification systemfor eukaryotic transposable elements. Nat Rev Genet 2007; 8: 973-82.
124. Esquela-Kerscher A, Slack FI. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
125. Need AC, Attix DK, McEvoy JM, et al. A genome-wide srudy of common SNPs and CNVs in cognitive performance in the CANTAB. Hum Mol Genet 2009; 18: 4650-61.
126. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-92.
127. Henning SM, Wang P, Said J, et al. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem 2012; Mar 7. [Epub ahead of print].
128. Atawodi SE. Nigerian foodstuffs with prostate cancer chemopreventive polyphenols. Infect Agent Cancer 2011; 6 Suppl 2: S9.
129. Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J Nutr 2007; 137: 223S-228S.
130. Williams JD, Jacobson EL, Kim H, Kim M, Jacobson MK. Folate in skin cancer prevention. Subcell Biochem 2012; 56: 181-97.
131. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-1308.
132. Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011; 65: 1016-26.